Preclinical evidence of the efficacy of cucurbita... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/14-668" }, "headline": "Preclinical evidence of the efficacy of cucurbita plants in diabetes management: a systematic review", "datePublished": "2025-07-07T17:00:14", "dateModified": "2025-07-07T17:00:14", "author": [ { "@type": "Person", "name": "Nancy Bonareri Mitaki" }, { "@type": "Person", "name": "Ilemobayo Victor Fasogbon" }, { "@type": "Person", "name": "Augustine Oviosun" }, { "@type": "Person", "name": "Samuel Mong’are" }, { "@type": "Person", "name": "Angela Mumbua Musyoka" }, { "@type": "Person", "name": "Vivian Onyinye Ojiakor" }, { "@type": "Person", "name": "Swase Dominic Terkimbi" }, { "@type": "Person", "name": "Peter Chinedu Agu" }, { "@type": "Person", "name": "Wusa Makena" }, { "@type": "Person", "name": "Robert Siida" }, { "@type": "Person", "name": "Elizabeth Kemunto Mitaki" }, { "@type": "Person", "name": "Ibe Micheal Usman" }, { "@type": "Person", "name": "Esther Ugo Alum" }, { "@type": "Person", "name": "DANIEL EJIM UTI" }, { "@type": "Person", "name": "Lucy Aja" }, { "@type": "Person", "name": "Sana Noreen" }, { "@type": "Person", "name": "Tijjani Salihu Shinkafi" }, { "@type": "Person", "name": "Dayyabu Shehu" }, { "@type": "Person", "name": "Philippe Mounmbegna" }, { "@type": "Person", "name": "Patrick Maduabuchi Aja" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": "Diabetes mellitus (DM) remains a major global health problem and particularly in low to middle income countries both because of the increasing prevalence and as a result of lack of access to affordable and effective treatment. Given the limitations of current pharmacological treatments, such as side effects and poor compliance, there is increasing interest in natural plant-derived alternatives. This systematic review explores the anti-diabetic potential of Cucurbita species, members of the Cucurbitaceae family, which have demonstrated promising hypoglycemic, antioxidant, and insulinotropic activities in preclinical models. Following PRISMA 2020 criteria, a comprehensive search of PubMed, Scopus, and Web of Science identified 16 eligible preclinical studies published between 2016 and 2025 that met strict inclusion criteria. Extracts from Cucurbita maxima, C. moschata, C. ficifolia, and C. pepo were shown to significantly reduce blood glucose concentrations, enhance antioxidant enzyme activity, promote pancreatic β-cell regeneration, and improve lipid profiles in diabetic animal models. These effects were predominantly observed following oral administration, reflecting traditional usage patterns and supporting clinical translatability. The geographically diverse research landscape underscores the global ethnobotanical relevance of Cucurbita species as complementary or alternative treatments for DM. However, the review also highlights gaps in the research, including the need for further pharmacokinetic, toxicological, and clinical studies to validate the efficacy and safety of these botanicals and to inform the development of standardized phytotherapeutic interventions. Overall, Cucurbita plants present a compelling case for further investigation as adjunct or alternative treatments for diabetes mellitus." } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/14-668/v1", "name": "Preclinical evidence of the efficacy of cucurbita plants in diabetes..." } } ] } Home Browse Preclinical evidence of the efficacy of cucurbita plants in diabetes... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Mitaki NB, Fasogbon IV, Oviosun A et al. Preclinical evidence of the efficacy of cucurbita plants in diabetes management: a systematic review [version 1; peer review: awaiting peer review] . F1000Research 2025, 14 :668 ( https://doi.org/10.12688/f1000research.166533.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Systematic Review Preclinical evidence of the efficacy of cucurbita plants in diabetes management: a systematic review [version 1; peer review: awaiting peer review] Nancy Bonareri Mitaki https://orcid.org/0000-0002-9518-4900 1 , Ilemobayo Victor Fasogbon https://orcid.org/0000-0003-4362-9004 1 , Augustine Oviosun 1 , [...] Samuel Mong’are 2 , Angela Mumbua Musyoka https://orcid.org/0009-0001-4444-256X 1 , Vivian Onyinye Ojiakor 1 , Swase Dominic Terkimbi https://orcid.org/0000-0002-4205-1880 1 , Peter Chinedu Agu https://orcid.org/0000-0003-4739-2040 3,4 , Wusa Makena 1 , Robert Siida https://orcid.org/0000-0001-7773-0368 1 , Elizabeth Kemunto Mitaki 5 , Ibe Micheal Usman https://orcid.org/0000-0001-6624-1286 1 , Esther Ugo Alum https://orcid.org/0000-0003-4105-8615 1 , DANIEL EJIM UTI https://orcid.org/0000-0002-1129-1785 1,6 , Lucy Aja https://orcid.org/0009-0004-7031-5750 1 , Sana Noreen 7 , Tijjani Salihu Shinkafi 8,9 , Dayyabu Shehu 10 , Philippe Mounmbegna https://orcid.org/0000-0002-0207-1158 1 , Patrick Maduabuchi Aja https://orcid.org/0009-0006-2450-9460 1 Nancy Bonareri Mitaki https://orcid.org/0000-0002-9518-4900 1 , Ilemobayo Victor Fasogbon https://orcid.org/0000-0003-4362-9004 1 , [...] Augustine Oviosun 1 , Samuel Mong’are 2 , Angela Mumbua Musyoka https://orcid.org/0009-0001-4444-256X 1 , Vivian Onyinye Ojiakor 1 , Swase Dominic Terkimbi https://orcid.org/0000-0002-4205-1880 1 , Peter Chinedu Agu https://orcid.org/0000-0003-4739-2040 3,4 , Wusa Makena 1 , Robert Siida https://orcid.org/0000-0001-7773-0368 1 , Elizabeth Kemunto Mitaki 5 , Ibe Micheal Usman https://orcid.org/0000-0001-6624-1286 1 , Esther Ugo Alum https://orcid.org/0000-0003-4105-8615 1 , DANIEL EJIM UTI https://orcid.org/0000-0002-1129-1785 1,6 , Lucy Aja https://orcid.org/0009-0004-7031-5750 1 , Sana Noreen 7 , Tijjani Salihu Shinkafi 8,9 , Dayyabu Shehu 10 , Philippe Mounmbegna https://orcid.org/0000-0002-0207-1158 1 , Patrick Maduabuchi Aja https://orcid.org/0009-0006-2450-9460 1 PUBLISHED 07 Jul 2025 Author details Author details 1 Kampala International University - Western Campus, Bushenyi, Western Region, Uganda 2 Kisii University, Kisii, Kisii County, Kenya 3 Evangel University Akaeze, Okpoto, Ebonyi, Nigeria 4 Southwest University College of Pharmaceutical Sciences, Chongqing, Chongqing, China 5 Jomo Kenyatta University of Agriculture and Technology, Nairobi, Nairobi County, Kenya 6 Federal University of Health Sciences Otukpo, Otukpo, Benue, Nigeria 7 The University of Lahore, Lahore, Punjab, Pakistan 8 Victoria University, Kampala, Central Region, Uganda 9 Usmanu Danfodiyo University, Sokoto, Sokoto, Nigeria 10 Bayero University Faculty of Basic Medical Sciences, Kano, Kano, Nigeria Nancy Bonareri Mitaki Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Software, Writing – Original Draft Preparation Ilemobayo Victor Fasogbon Roles: Conceptualization, Formal Analysis, Methodology, Software, Writing – Original Draft Preparation Augustine Oviosun Roles: Conceptualization, Formal Analysis, Validation, Visualization, Writing – Original Draft Preparation Samuel Mong’are Roles: Data Curation, Investigation, Software, Validation, Visualization Angela Mumbua Musyoka Roles: Conceptualization, Methodology, Resources, Software, Writing – Original Draft Preparation, Writing – Review & Editing Vivian Onyinye Ojiakor Roles: Conceptualization, Formal Analysis, Methodology, Writing – Original Draft Preparation Swase Dominic Terkimbi Roles: Conceptualization, Investigation, Methodology, Validation, Writing – Original Draft Preparation Peter Chinedu Agu Roles: Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation Wusa Makena Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation Robert Siida Roles: Conceptualization, Methodology, Resources, Validation, Writing – Original Draft Preparation Elizabeth Kemunto Mitaki Roles: Data Curation, Investigation, Resources, Software, Validation Ibe Micheal Usman Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation Esther Ugo Alum Roles: Data Curation, Investigation, Software, Visualization, Writing – Original Draft Preparation DANIEL EJIM UTI Roles: Data Curation, Investigation, Resources, Software, Writing – Original Draft Preparation Lucy Aja Roles: Investigation, Resources, Software, Validation, Visualization Sana Noreen Roles: Data Curation, Investigation, Methodology, Software, Validation Tijjani Salihu Shinkafi Roles: Conceptualization, Formal Analysis, Methodology, Software, Supervision, Visualization, Writing – Original Draft Preparation Dayyabu Shehu Roles: Formal Analysis, Investigation, Methodology, Supervision, Validation, Visualization Philippe Mounmbegna Roles: Conceptualization, Methodology, Resources, Software, Supervision, Writing – Original Draft Preparation Patrick Maduabuchi Aja Roles: Conceptualization, Formal Analysis, Methodology, Resources, Supervision, Writing – Review & Editing OPEN PEER REVIEW REVIEWER STATUS AWAITING PEER REVIEW This article is included in the Plant Science gateway. Abstract Diabetes mellitus (DM) remains a major global health problem and particularly in low to middle income countries both because of the increasing prevalence and as a result of lack of access to affordable and effective treatment. Given the limitations of current pharmacological treatments, such as side effects and poor compliance, there is increasing interest in natural plant-derived alternatives. This systematic review explores the anti-diabetic potential of Cucurbita species, members of the Cucurbitaceae family, which have demonstrated promising hypoglycemic, antioxidant, and insulinotropic activities in preclinical models. Following PRISMA 2020 criteria, a comprehensive search of PubMed, Scopus, and Web of Science identified 16 eligible preclinical studies published between 2016 and 2025 that met strict inclusion criteria. Extracts from Cucurbita maxima , C. moschata , C. ficifolia , and C. pepo were shown to significantly reduce blood glucose concentrations, enhance antioxidant enzyme activity, promote pancreatic β-cell regeneration, and improve lipid profiles in diabetic animal models. These effects were predominantly observed following oral administration, reflecting traditional usage patterns and supporting clinical translatability. The geographically diverse research landscape underscores the global ethnobotanical relevance of Cucurbita species as complementary or alternative treatments for DM. However, the review also highlights gaps in the research, including the need for further pharmacokinetic, toxicological, and clinical studies to validate the efficacy and safety of these botanicals and to inform the development of standardized phytotherapeutic interventions. Overall, Cucurbita plants present a compelling case for further investigation as adjunct or alternative treatments for diabetes mellitus. READ ALL READ LESS Keywords Diabetes , Cucurbita , Corresponding Author(s) Angela Mumbua Musyoka ( [email protected] ) Close Corresponding author: Angela Mumbua Musyoka Competing interests: No competing interests were disclosed. Grant information: The author(s) declared that no grants were involved in supporting this work. Copyright: © 2025 Mitaki NB et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Mitaki NB, Fasogbon IV, Oviosun A et al. Preclinical evidence of the efficacy of cucurbita plants in diabetes management: a systematic review [version 1; peer review: awaiting peer review] . F1000Research 2025, 14 :668 ( https://doi.org/10.12688/f1000research.166533.1 ) First published: 07 Jul 2025, 14 :668 ( https://doi.org/10.12688/f1000research.166533.1 ) Latest published: 07 Jul 2025, 14 :668 ( https://doi.org/10.12688/f1000research.166533.1 ) Introduction Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia that persists over time as a consequence of insufficient insulin secretion, improper insulin action, or a combination of both. As such, it accounts for several diseases, including cardiovascular disease, neuropathy, retinopathy, and nephropathy. The international burden of diabetes has been worsening with projections estimating approximately 830 million diabetes cases in 2022, with a disproportionate focus on low- and middle-income countries ( World health organization, 2024 ). Diabetes can be classified as Type 1 diabetes, which is an autoimmune condition that results in the destruction of the pancreatic β-cells, and, Type 2 diabetes, which occurs after a person has developed insulin resistance and β-cell dysfunction ( American Diabetes Association, 2023 ). Currently treatment remains focused on drugs, primarily metformin and insulin, but the adverse effects, expenditure, and adherence problems have increased the attention towards alternative drugs developed from natural resources ( Mooradian et al., 2022 ). Some of the natural plants investigated for their anti-diabetic properties include the members of the Cucurbitaceae family like, Cucurbita máxima, Cucurbita ficifolia, and Cucurbita moschata. These plants have bioactive compounds such as phenolics, flavonoids, polysaccharides, cucurbitacins which have hypoglycemic, antioxidant and anti-inflammatory activities ( Suwannapong et al., 2023 ). For instance, some preclinical studies showed that extracts of Cucurbita ficifolia activated peroxisome proliferator-activated receptors (PPARs) that control lipid and glucose metabolism resulting in significant reduction of blood glucose levels streptozotocin induced diabetic mice ( Rojas et al., 2021 ). In the same way, some extracts of Cucurbita maxima have been shown to regenerate pancreatic β-cells and augment insulin secretion in alloxan diabetic rats ( Mujtaba et al., 2022 ). This is the reason why these plants should be investigated further for their potential use in diabetes management. Alongside their hypoglycemic effects, members of the Cucurbita genus demonstrate the ability to counter oxidative stress, which is a diabetes complication, through strong antioxidant activity. For example, a study conducted on the extracts of Cucumis sativus and Cucurbita maxima found that these extracts were successful in reversing the diabetic rats’ liver and pancreas functionality and normalizing the oxidative stress parameters ( Suwannapong et al., 2023 ). Moreover, cucurbitacins, a subclass of triterpenes belonging to the family of Cucurbitaceae plants, have been reported to possess insulin-like activity by increasing glucose utilization and the insulin sensitivity ( Bhatti et al., 2021 ). These multifaceted effects suggest that Cucurbita plants could serve as valuable alternatives to conventional diabetes therapies. This systematic review intends to scrutinize their mechanisms of action and evaluate therapeutic possibilities and translational avenues by analyzing abundant preclinical studies that verify the anti-diabetic activity of Cucurbita species. By bringing together the findings of recent studies, this review intends to clarify how these plants may be useful in the management of diabetes. Moreover, it points out the insufficiencies of research that need to be conducted to enable the use of these promising natural products in clinical settings. Methodology Search strategy The review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines ( Page et al., 2021 ; Swase et al., 2025 ). A systematic and comprehensive literature search was conducted on January 17, 2025, across the Web of Science (WoS), Scopus, and PubMed databases. The search strategy utilized the keywords “cucurbita” and “diabetes,” incorporating Boolean operators (AND/OR/NOT), alternative terms, and search modifiers such as quotation marks, parentheses, wildcards, and asterisks (*) ( Fasogbon et al., 2023, 2024 ; Mitaki et al., 2024 ). The search was restricted to peer-reviewed English-language publications published between 2016 and January 17, 202. Eligibility criteria Article selection adhered to the following inclusion and exclusion criteria: preclinical studies involving animal models such as rats, mice, and rabbits, as well as other non-human models demonstrating the role of Cucurbita in diabetes management or prevention. Only studies specifically addressing protective or therapeutic interventions for diabetes mellitus were included. To ensure scientific rigor, only peer-reviewed articles published in English were considered. Additionally, the review focused on studies involving at least one of the following Cucurbita species: C. argyrosperma, C. ficifolia, C. maxima, C. moschata, and C. pepo. The time frame was restricted to publications from 2016 to 2025 to ensure that the findings reflect current research trends. Furthermore, studies were required to report interventions and outcomes in measurable terms, such as biochemical parameters, treatment duration, and statistical significance (e.g., p-values). Conversely, studies were excluded if they did not focus on diabetes therapy or management, including those addressing diabetes insipidus or other unrelated conditions. Clinical trials involving human participants were also excluded. Non-English publications, as well as those investigating Cucurbita species outside the specified five, were not considered. Additionally, review articles, editorials, commentaries, conference abstracts, and book chapters were excluded, as were studies that lacked sufficient methodological details, did not report clear outcome measures, or failed to provide statistical validation of their findings. Study selection and data extraction The database search results were uploaded to the Rayyan online platform ( Johnson & Phillips, 2018 ). Duplicate records were identified using Rayyan’s duplicate detection feature, followed by manual validation and removal. Angela Mumbua Musyoka and Nancy Bonarere Mitaki independently screened the records in two stages: title and abstract screening, followed by full-text review. Multiple publications originating from the same study were grouped, with the primary publication selected based on its relevance to the research question. Any discrepancies during the screening process were resolved through discussions between Angela Mumbua Musyoka and Nancy Bonareri Mitaki. The data presented in Table 1 were extracted from each eligible study. Table 1. Data extracted from included articles. Category Details Study Design Type of preclinical model (e.g., rat, mouse, rabbit, drosophila), Method of diabetes induction (e.g., streptozotocin, alloxan, genetic models), Study design specifics (e.g., sample size, control groups) Intervention Details Cucurbita species used, Plant part utilized (e.g., seed, leaf, fruit, stem), Extraction method (e.g., aqueous, ethanolic), Phytochemicals analyzed or quantified Treatment Protocol Duration of intervention, Dose administered (quantity and frequency), Delivery method (oral, injection, etc.) Outcome Measures Biochemical parameters (e.g., blood glucose levels, HbA1c, lipid profiles), Mechanistic insights (e.g., antioxidant activity, insulin sensitivity, pancreatic regeneration), Protective or therapeutic effects, Statistical significance (p-values) Geographical and Contextual Information Country of origin of the study, Cultural or regional relevance of Cucurbita use in traditional medicine Risk of Bias Assessment Quality and transparency of methods, Conflict of interest and funding sources Key Findings and Conclusions Primary outcomes, Secondary outcomes, Study limitations noted by authors Results Search results The Scopus search retrieved 88 articles, Web of Science identified 53, and PubMed yielded 29, resulting in a total of 170 articles across the three databases. The search results were screened on the Rayyan platform based on the predefined inclusion and exclusion criteria. During this process, 66 duplicate articles were identified and removed. The remaining 104 records underwent an initial title and abstract screening, leading to the exclusion of 78 articles. A subsequent full-text review eliminated 10 more articles for not meeting the inclusion criteria. Ultimately, 16 articles met the eligibility and quality assessment requirements and were included in the study ( Figure 1 ). Figure 1. PRISMA flow chart for study selection. Results Results from this systematic review are presented in Tables 1 , 2 and Figures 1 – 6 below. Figure 1 illustrates the various plant parts of Cucurbita species that were utilized across the included studies for anti-diabetic research. Parts used include: Seeds, Fruit pulp, Leaves, Flowers, and Juice. This reflects the versatility of Cucurbita plants, indicating that multiple parts contain bioactive compounds with potential therapeutic effects against diabetes. Figure 3 shows the specific species of Cucurbita evaluated in the review, which include: Cucurbita maxima, Cucurbita moschata, Cucurbita pepo, and Cucurbita ficifolia. Cucurbita maxima and Cucurbita moschata were the most frequently studied species, indicating their prominence in traditional medicine and potential pharmacological interest. Table 2. Showing the phytochemical evaluation, mechanism of action and geographical location of included studies. S/No Plant Extraction solvent Phytochemical Mechanism of action/key findings Country References 1. Cucurbita maxima Aqueous Not Done Decrease blood sugar levels by stimulating insulin secretion from pancreatic beta cells. India Kushawaha et al., 2017 2. Cucurbita ficifolia Aqueous NMR and GC-MS, p coumaric acid, p- hydroxybenzoic acid, salicin, stigmast-7,2,2-dien-3-ol and stigmast-7-en-3-ol Exhibits antioxidant, anti-inflammatory and hepatoprotective properties. Mexico Garcia et al., 2017 3. Cucurbita moschata durch Seed powder suspended in sodium carboxymethyl cellulose (CMC) 0.5% Flavonoids, Saponins, Tannins Decrease blood sugar level by stimulating pancreatic secretion of insulin from existing β-cell. Indonesia Marbun & Rumanti, 2019 4. Cucurbita maxima Aqueous Not Done Decrease blood sugar level via release of insulin from pancreas β-cell. Decrease AST, ALT and total cholesterol level. Iraq Kadhum et al., 2020 5. Cucurbita moschata Durch Water and ethanol Polysaccharide Antioxidative properties characterized by increased GPx, SOD & CAT. Decreased MDA and blood sugar level reduction. China Yang et al., 2024 6. Cucurbita moschata Duchesne & Cucurbita maxima Duchesne Aqueous & ethanol Polysaccharide, Total phenol, total flavonoids pancreatic regeneration (via increased beta-cell number/size) to reduce blood glucose levels and antioxidant mechanisms (DPPH scavenging and ferric ion reduction) to counteract oxidative stress. Thailand Suwannapong et al., 2023 7. Cucurbita maxima Methanol 3,5dihydroxyphenol, genkwanin, Zearalenone estrogenic metabolite, hexamethaylinoic acid, hydroquinine, L-histidin,3 methyl, alpinetin and La-arginine Antioxidative properties characterized by increased GST, GSH and CAT activities, decreased MDA & NO. Decrease in the blood sugar level. Hypoglycemic effect via improvement of the immunohistochemical expression of insulin in b-cells of islets of Langerhans. Egypt Atta et al., 2020 8. Cucurbita maxima Aqueous & ethanol Flavonoids, Fatty acids phenolic acids Anti-diabetic effect through reduction blood glucose levels and restore pancreatic β-cells. Reduce the endogenous synthesis of glucose by the liver. Kenya Njoki et al., 2024 9. Cucurbita pepo Fruit juice Not done Anti-diabetic effect via reduction in blood glucose. Iran Sayahi & Shirali, 2018 10. Cucurbita maxima Seed powder Total Phenolic Total flavonoids, Fatty acids (oleic acid, linoleic acids) Hypoglycemic, hypolipidemic, and liver protective effects by reducing blood glucose, cholesterol, triglycerides, LDL, and liver enzymes (ALT, AST). Egypt Farid et al., 2015 11. Cucurbita moschata Not specific Carbohydrates, proteins, minerals Reduced fasting blood glucose level, increased hepatic glycogen, enhance the islet cells proliferation activity. China Wang et al., 2017 12. Cucurbita maxima Aqueous Phenol, Flavonoids, Anthocyanins Improvement of Lipid Profile: Decreases total cholesterol (TC), LDL, VLDL, and triglycerides (TG). Liver Enzyme Reduction: (ALT), (ALP), (AST) Antioxidant properties: Increases serum insulin, HDL, Superoxide dismutase (SOD), Catalase (CAT), and reduced glutathione (GSH). Saudi Arabia Elsadek et al., 2024 13. Cucurbita pepo Aqueous Polysaccharide Anti-diabetic activity by decreasing blood glucose level, inhibiting α-glucosidase and α-amylase activities and improving pancreas tissue damage. Vietnam Thanh et al., 2021 14. Cucurbita moschata Duch Water and alcohol Polysaccharide Reduced fasting blood glucose levels, increase antioxidant enzyme activities i.e CAT, GR, GSH, decreased MDA, stimulating the secretion of endogenous GLP-1, decreasing oxidative damages. China Lu et al., 2019 15. C. ficifolia bouche Aqueous Not done Hypoglycemic effect. Mexico Moya-Hernández et al., 2018 16. Cucurbita pepo Ethanol Not done Reduced blood sugar level. Jordan Alkofahi et al., 2017 Figure 2. Different parts of the Cucurbita plant used in this review. Figure 3. Cucurbita species examined in the studies included in this systematic review. Figure 4. The common mechanism of action and key finding for most of the studies. ALT – Alanine Aminotransferase, MDA – Malondialdehyde, SOD – Superoxide Dismutase, GSH – Glutathione, GR – Glutathione Reductase, Alkaline Phosphatase, CAT – Catalase, Glucagon-Like Peptide-1, HDL – High-Density Lipoprotein, LDL – Low-Density Lipoprotein, AST – Aspartate Transaminase. Figure 5. Route of administration of Cucurbita species in the studies included in this review. Figure 6. Illustrating the geographical spread of the articles included in this systematic review, highlighting the countries or regions where the research was conducted. Table 1 reveals that Cucurbita species possess multiple bioactive compounds with diverse therapeutic effects targeting key pathophysiological aspects of diabetes. The hypoglycemic activity is mediated by stimulating insulin secretion, pancreatic regeneration, antioxidant defenses, and improvement in lipid metabolism. The widespread geographical focus of studies underpins the global relevance and ethnobotanical value of Cucurbita plants in managing diabetes. Table 3 summarizes the experimental protocols of Cucurbita species in diabetes management. Most studies used oral administration of aqueous or ethanol extracts over 2–4 weeks, with doses ranging from 50 mg/kg to 1 g/kg. Streptozotocin was the most common diabetes-inducing agent, while glibenclamide was frequently used as the standard control drug. Rats, particularly Wistar and albino strains, were the predominant animal models. The findings confirm the hypoglycemic potential of Cucurbita species, acting through insulin stimulation, antioxidant effects, and pancreatic protection, supporting their ethnomedicinal use in diabetes management. Figure 4 summarizes mechanisms such as: enhancement of antioxidant enzymes (SOD, CAT, GSH, GR), reduction of oxidative stress markers (MDA), insulin secretion and pancreatic regeneration, lipid profile improvement (lowering LDL, triglycerides), liver enzyme reduction (ALT, AST, ALP). A multi-target approach in diabetes management using Cucurbita species enhances therapeutic outcomes by addressing hyperglycemia, oxidative stress, and lipid metabolism. Table 3. Showing treatment protocol, animal model and mode of administration. S/No Cucurbita species Duration of intervention Dosage Diabetics induction Standard drug control Animal strain Route of administration Author/Date 1. Cucurbita maxima 28 days 50, 100, 150, 200 and 250 mg/kg Streptozotocin Glibenclimide Albino rats Orally Kushawaha et al., 2017 2. Cucurbita ficifolia 30 days 200 mg/kg Alloxan Glibenclimide Male mice Orally Garcia et al., 2017 3. Cucurbita Moschata durch 15 days 100, 150, and 200 mg/kg Streptozotocin Glibenclimide Male mice Orally Marbun & Rumanti, 2019 4. Cucurbita maxima 4 weeks 300 mg/kg Alloxan No standard drug Female swiss mice Orally Kadhum et al., 2020 5. Cucurbita Moschata Durch 7 weeks 100 & 200 mg/kg Streptozotocin Acarbose Male Mice Orally Yang et al., 2024 6. Cucurbita moschata Duchesne & Cucurbita maxima Duchesne 6 weeks 500 mg/kg Streptozotocin Glibenclimide Male albino Wistar rats Orally Suwannapong et al., 2023 7. Cucurbita maxima 28 days 200 & 400 mg/kg Alloxan Glibenclimide Wistar rats Orally Njoki et al., 2024 8. Cucurbita maxima 21 days 200 & 400 mg/kg Streptozotocin Metformin Sprague Dawley rats (male and Female) Orally Atta et al., 2020 9. Cucurbita pepo L 30 days 500 mg/kg Streptozotocin No standard drug Male Albino rats Orally Sayahi & Shirali, 2018 10. Cucurbita maxima 30 days 3% of pumpkin powder Alloxan No standard drug Male albino rats Orally Farid et al., 2015 11. Cucurbita moschata 1 day 150 mg/kg Alloxan Xiaoke pill Male mice IP Wang et al., 2017 12. Cucurbita maxima NS Cucurbita maxima flowers (CMF-10% and 20%) Alloxan No standard drug Adult male albino rats orally Elsadek et al., 2024 13. Cucurbita pepo 7 days 100 mg/kg/day Alloxan Chlorpropamide Mice NS Thanh et al., 2021 14. Cucurbita moschata Duch 3 weeks 150 mg/kg Streptozotocin Acarbose Adult Male Wistar rats Orally Lu et al., 2019 15. Cucurbita ficifolia 6 hour 500 mg/kg No-Induction Glibenclamide Male Mice IP Moya-Hernández et al., 2018 16. Cucurbita pepo 3 hours 1 g/kg Alloxan Glibenclamide Sprague Dawley rats Orally Alkofahi et al., 2017 * IP = Intraperitoneally, NS = Not specific. Figure 5 illustrates the route of administration. The majority of the included studies administered Cucurbita extracts orally, reflecting the traditional usage and potential for formulation into oral therapeutics. One study employed intraperitoneal (IP) administration. The oral route’s predominance supports its feasibility in human therapeutic applications. Figure 6 summarizes the geographical spread of studies. This figure illustrates a global distribution of research, with notable contributions from: Asia (India, China, Thailand, Iraq, Indonesia), Africa (Egypt, Kenya), South America (Mexico), the Middle East (Iran, Jordan), and Southeast Asia (Vietnam). The wide geographical distribution indicates the global recognition of Cucurbita species as potential anti-diabetic agents. Figure 7 shows the types and numbers of standard Anti-diabetic drugs used. This depicts the various standard anti-diabetic drugs used in comparison across studies, including: Glibenclamide, Metformin, Acarbose, Chlorpropamide and Xiaoke pill (herbal standard). Most studies used glibenclamide as the standard control drug, enabling a comparative evaluation of Cucurbita’s efficacy against established pharmacological agents. Figure 7. Illustrating the number and types of standard anti-diabetic drugs reported across the included studies. This systematic review provides robust preclinical evidence that various species and parts of the Cucurbita plant possess significant anti-diabetic properties. These effects are mediated through multiple mechanisms, including hypoglycemic activity, antioxidant defense, pancreatic regeneration, and lipid profile modulation. The studies span a wide geographical range, highlighting global interest. Oral administration remains the predominant route, enhancing the clinical translatability of these findings. Discussion Phytotherapy has continued to expand as a readily available and cost-effective management strategy for different diseases worldwide. In this study, the findings highlighted in Figures 1 and 2 present critical insights into the phytomedical use of Cucurbita species in diabetes management. Our study showed diverse plant parts, including seeds, fruit pulp, leaves, flowers, and juice, were used, underscoring the botanical versatility of the genus Cucurbita ( Kushawaha et al., 2017 ; Yang et al., 2024 ). Similarly, this broad spectrum of plant parts suggests a widespread distribution of bioactive phytochemicals throughout the plant architecture ( George & Brandl, 2021 ). According to our findings, such compounds may include flavonoids, polyphenols, saponins, alkaloids, and polysaccharides, many of which have been previously reported to exhibit antidiabetic properties through mechanisms like insulin sensitization, β-cell protection ( Kadhum et al., 2020 ), inhibition of carbohydrate-hydrolyzing enzymes, and modulation of oxidative stress ( Atta et al., 2020 ). Additionally, the predominance of Cucurbita maxima and Cucurbita moschata in the reviewed literature reflects their established role in ethnomedicine and greater accessibility in various cultures ( Lu et al., 2019 ; Farid et al., 2015 ; Agu et al., 2022 ). This pattern may also be influenced by their favorable agronomic traits, nutritional value, and broader commercial availability, which make them more attractive for preclinical investigation. Importantly, both species have demonstrated diverse pharmacological actions in diabetic models, reinforcing their candidacy for further translational research and potential development into phytotherapeutic agents. Furthermore, these findings support the rationale for exploring multiple Cucurbita species and plant parts in preclinical diabetes research and emphasize the importance of a holistic phytochemical profiling approach. However, comparative studies that directly evaluate the antidiabetic efficacy of different parts and species under standardized conditions remain sparse and are warranted to guide evidence-based selection for clinical translation. One of the interests in phytotherapy research is to elucidate the molecular mechanisms of action. In this study, the evidence presented in Table 1 and summarized in Table 2 and Figure 6 robustly affirms the multi-targeted antidiabetic mechanisms of Cucurbita species, substantiating their longstanding use in traditional medicine. According to the available data, the convergence of bioactivity across multiple studies reveals a complex pharmacodynamic profile, with extracts from Cucurbita plants mediating therapeutic effects through both pancreatic and extra-pancreatic pathways ( Suwannapong et al., 2023 ). Notably, the stimulation of insulin secretion and pancreatic β-cell regeneration suggests the presence of insulinotropic agents within Cucurbita phytoconstituents ( Rorsman and Ashcroft, 2018 ). This effect is particularly significant in type 1 and late-stage type 2 diabetes models, where β-cell integrity is compromised. Similarly, the improvement in lipid profiles and reduction of hepatic enzymes further indicate systemic metabolic benefits, reinforcing the potential of Cucurbita in managing diabetic dyslipidemia and hepatopathy, which are common comorbidities in poorly controlled diabetes ( Atta et al., 2020 ). Additionally, the upregulation of endogenous antioxidant enzymes (SOD, CAT, GSH, GR) and suppression of lipid peroxidation marker MDA suggest that Cucurbita extracts confer substantial oxidative stress mitigation ( Elsadek et al., 2024 ). Invariably, this is especially relevant given the critical role of oxidative stress in the pathogenesis and progression of diabetes and its complications ( Agu et al., 2023a ). Again, the multi-target nature of Cucurbita bioactivity, spanning glycemic control, oxidative defense, hepatic protection, and lipid modulation, aligns well with the modern paradigm of polypharmacology in chronic disease management. From a methodological perspective, as observed in this study, the use of streptozotocin (STZ) to induce diabetes reflects a well-established model for replicating β-cell destruction and mimicking human diabetic pathology ( Kushawaha et al., 2017 ; Yang et al., 2024 ). The frequent use of glibenclamide as a standard drug control reinforces the credibility of comparative efficacy assessments ( Njoki et al., 2024 ). However, variability in extract preparation, dose ranges (50 mg/kg to 1 g/kg), and treatment duration (2–4 weeks) may introduce heterogeneity, underscoring the need for standardized protocols in future investigations. Furthermore, geographical diversity in the studies extracted further emphasized the trans-cultural relevance of Cucurbita in diabetes management, supporting its candidacy for global ethnopharmacological development ( Suwannapong et al., 2023 ). Therefore, these findings collectively advocate for advancing Cucurbita species into more rigorous pharmacokinetic, toxicological, and eventually clinical evaluations. In this study, we observed an overwhelming preference by researchers for oral administration of Cucurbita extracts ( Figure 6 and Table 3 ). This mirrors traditional ethnomedicinal practices and is pharmacologically significant. For instance, oral administration not only ensures ease of delivery and patient compliance but also suggests that the bioactive constituents of Cucurbita are sufficiently stable to survive gastrointestinal conditions and reach systemic circulation in biologically active forms. We maintained that this enhances the plausibility of transitioning these extracts or their active fractions into standardized oral formulations, such as capsules, teas, or nutraceutical supplements ( Agu et al., 2023b ). Additionally, the solitary use of the intraperitoneal route, while less relevant for human therapy, may have been employed for mechanistic or absorption-focused studies, but does not detract from the overarching translational value demonstrated by the oral route dominance ( Al Shoyaib et al., 2019 ). Furthermore, as shown in Figure 6 , a geographically diverse body of literature from Asia, Africa, South America, the Middle East, and Southeast Asia suggests Cucurbita’s global ethnobotanical prominence and research appeal ( World Health Organization, 2024 ). This broad-based validation points to a rich cross-cultural heritage of therapeutic use. It also suggests ecological and biochemical variability within Cucurbita species that may influence their phytochemical profiles and, consequently, their therapeutic effects. This is a compelling argument for comparative ethnopharmacological studies that examine regional chemovariants and their specific bioactivities. Another interesting observation in Figure 7 was the comparative use of standard antidiabetic agents, most notably glibenclamide, and others like metformin, acarbose, chlorpropamide, and the Xiaoke pill. This multi-standard framework allows for a nuanced benchmarking of Cucurbita’s efficacy across pharmacological classes: sulfonylureas (glibenclamide, chlorpropamide), biguanides (metformin), α-glucosidase inhibitors (acarbose), and polyherbal formulations (Xiaoke pill) ( Spengler et al., 1992 ; Marre et al., 2002 ; Mujtaba et al., 2022 ). We suggest that the repeated use of glibenclamide enhances interpretability across studies, as it serves as a well-characterized reference with known insulinotropic effects ( Garber et al., 2006 ). Therefore, Cucurbita extracts exhibit comparable or complementary effects to these standards in many studies, indicating their strong pharmacological promise. Conclusion This systematic review has provided compelling preclinical evidence that Cucurbita species possess significant antidiabetic potential through a multi-targeted mechanism involving insulin secretion, pancreatic regeneration, antioxidant enhancement, lipid profile improvement, and hepatic protection. Additionally, the use of various plant parts, most commonly administered orally, and the widespread global investigation across diverse geographic regions underscored the ethnomedicinal relevance and translational feasibility of Cucurbita-based phytotherapies. Furthermore, comparative efficacy against standard antidiabetic drugs further validates their pharmacological promise. Collectively, we propose that these findings support the advancement of Cucurbita species into standardized formulations and clinical studies as complementary or alternative agents in diabetes mellitus management. Ethics and consent statement Ethical approval and consent were not required. Data availability All datasets can be accessed in the open science framework (OSF) under: Repository link: https://osf.io/8y9wm/files/osfstorage DOI: 10.17605/OSF.IO/8Y9WM ( Musyoka et al., 2025 ). License: CC0 1.0 Universal References Agu PC, Afiukwa CA, Orji OU, et al. : Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in disease management. Sci. Rep. 2023a; 13 (1): 13398. PubMed Abstract | Publisher Full Text | Free Full Text Agu PC, Aja PM, Ezeh EM, et al. : Neuroprotective Potentials of Ageratum conyzoides Phyto-constituents via Inhibition of Monoamine Oxidase: An In-silico Study. Nigerian Journal of Biochemistry and Molecular Biology. 2023b; 38 (1). Agu PC, Ezeh EM, Nwosu CI: Characterization of Nutritional and Phytochemical Compositions of Locally Consumed Leafy Vegetables from Afikpo, Ebonyi State, Nigeria. Caritas Journal of Physical and Life Sciences. 2022; 1 (1): 1–7. Alkofahi AS, Abdul-Razzak KK, Alzoubi KH, et al. : Screening of the Anti-hyperglycemic activity of some medicinal plants of Jordan. Pak. J.Pharm. Sci. 2017; 30 (3): 907–912. PubMed Abstract Al Shoyaib A, Archie SR, Karamyan VT: Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies Pharm. Res. 2019; 37 (1): 12. PubMed Abstract | Publisher Full Text | Free Full Text American Diabetes Association: Standards of Medical Care in Diabetes—2023. Diabetes Care. 2023; 46 (Suppl 1): S1–S291. Atta AH, Saad SA, Atta SA, et al. : Cucumis sativus and Cucurbita maxima extract attenuate diabetes-induced hepatic and pancreatic injury in a rat model. J.Physiol. Pharmacol. 2020; 71 (4). Bhatti IU, Shahid MA, Khan AW, et al. : Insulin-like activity of cucurbitacins from Cucurbitaceae plants: A potential antidiabetic mechanism. Phytomedicine. 2021; 90 (3): 153–161. Elsadek MF, Chen TW, Al-Numair KS, et al. : Aberrant hepatic glucose levels and cellular damage reversed by Cucurbita maxima blossoms on experimental models. J. King Saud Univ. Sci. 2024; 36 (10): 103452. Publisher Full Text Farid HE, El-Sayed SM, Abozid MM: Pumpkin and sunflower seeds attenuate hyperglycemia and protect liver in alloxan-induced diabetic rats.2015. Fasogbon IV, Aja PM, Ondari EN, et al. : UCP-LF and other assay methods for schistosome circulating anodic antigen between 1978 and 2022. Biol. Methods Protoc. 2023; 8 (1). PubMed Abstract | Publisher Full Text | Free Full Text Fasogbon IV, Ondari EN, Deusdedit T, et al. : Point-of-care potentials of lateral flow-based field screening for Mycoplasma bovis infections: a literature review. Biol. Methods Protoc. 2024; 9 (1): bpae034. PubMed Abstract | Publisher Full Text | Free Full Text Garber A, Klein E, Bruce S, et al. : Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2diabetes inadequately controlled on metformin monotherapy. Diabetes. Obes. Metab. 2006; 8 (2): 156–163. PubMed Abstract | Publisher Full Text Garcia JG, Garcia ML, Zamilpa A, et al. Chemical characterization of a hypoglycemic extract from Cucurbita ficifolia Bouche that induces liver glycogen accumulation in diabetic mice. Afr. J. Tradit. Complement. Altern. Med. 2017; 14 (3):218–230. George AS, Brandl MT: Plant Bioactive Compounds as an Intrinsic and Sustainable Tool to Enhance the Microbial Safety of Crops. Microorganisms. 2021; 9 (12): 2485. PubMed Abstract | Publisher Full Text | Free Full Text Johnson N, Phillips M: Rayyan for systematic reviews. J.Electron. Resour. Librariansh. 2018; 30 (1): 46–48. Publisher Full Text Kadhum RJ, Obaid QA, Ahmed AJ, et al. : Comparative study of physiological effect of lemon juice and aqueous extract of pumpkin fruits on diabetic female mice. Plant Archives. 2020; 20 (1): 922–926. Kushawaha DK, Yadav M, Chatterji S, et al. : Evidence based study of antidiabetic potential of C.maxima seeds–In vivo. J.Tradit. Complement. Med. 2017; 7 (4): 466–470. PubMed Abstract | Publisher Full Text | Free Full Text Lu A, Yu M, Fang Z, et al. : Preparation of the controlled acid hydrolysates from pumpkin polysaccharides and their antioxidant and antidiabetic evaluation. Int. J.Biol. Macromol. 2019; 121 : 261–269. PubMed Abstract | Publisher Full Text Marbun N, Rumanti RN: Effects of pumpkin (Cucurbita moschata durch) seed powder on blood glucose level in streptozotocin-induced mice. Asian J.Pharm. Clin. Res. 2019; 12 (8): 2019. Marre M, Howlett H, Lehert P, et al. : Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2diabetic patients inadequately controlled on metformin. Diabet. Med. 2002; 19 (8): 673–680. PubMed Abstract | Publisher Full Text Mitaki NB, Fasogbon IV, Ojiakor OV, et al. : A Systematic Review Of Plant-Based Therapy For The Management Of Diabetes Mellitus In The East Africa Community. Phytomedicine Plus. 2024; 100717. Mooradian AD: Emerging therapies for diabetes mellitus: A focus on natural products. Endocr. Pract. 2022; 28 (5): 456–468. Moya-Hernández A, Bosquez-Molina E, Serrato-Díaz A, et al. : Analysis of genetic diversity of Cucurbita ficifolia Bouché from different regions of Mexico, using AFLP markers and study of its hypoglycemic effect in mice. S.Afr. J.Bot. 2018; 116 : 110–115. Publisher Full Text Mujtaba MA, Fatima S, Khan MA, et al. : Regeneration of pancreatic β-cells by ethanolic extract of Cucurbita maxima seeds in alloxan-induced diabetic rats: A histopathological study. BMC Complement. Med. Ther. 2022; 22 (1): 45–53. Musyoka AM, Mitaki NB, Fasogbon IV, et al. : Preclinical evidence of the efficacy of cucurbita plants in diabetes management: A systematic review.2025, June 26. Publisher Full Text Njoki MP, Rebecca W, Shadrack M, et al. : Effect of aqueous and ethanol extracts of Cucurbita maxima seed on fasting blood glucose in alloxan-induced rats.2024. Page MJ, McKenzie JE, Bossuyt PM, et al. : The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ. 2021; 372 . PubMed Abstract | Publisher Full Text | Free Full Text Rojas P, Román-Ramos R, Alarcón-Aguilar FJ, et al. : Hypoglycemic activity of Cucurbita ficifolia extract via PPAR activation in diabetic mice. J.Med. Plant Res. 2021; 15 (8): 123–130. Rorsman P, Ashcroft FM: Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men. Physiology Review. 2018; 98 (1): 117–214. PubMed Abstract | Publisher Full Text | Free Full Text Sayahi M, Shirali S: Study of Cucurbita extract effect on changes of AGEs, lipid and glycemic profile and CRP in type 1diabetic rats. Bangladesh J. Med. Sci. 2018; 17 (1): 84–87. Publisher Full Text Spengler M, Hänsel G, Boehme K: Efficacy of 6months monotherapy with glucosidase inhibitor Acarbose versus sulphonylurea glibenclamide on metabolic control of dietary treated type II diabetics (NIDDM). Horm. Metab. Res. Suppl. 1992; 26 : 50–51. Suwannapong A, Talubmook C, Promprom C, et al. : Evaluation of Antidiabetic and Antioxidant Activities of Fruit Pulp Extracts of Cucurbita moschata Duchesne and Cucurbita maxima Duchesne. J.Ethnopharmacol. 2023; 312 : 1124606. Swase TD, Fasogbon IV, Eseoghene IJ, et al. : The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers. BMC Cancer. 2025; 25 (1): 1–15. Publisher Full Text Thanh TTT, Quach TTM, Yuguchi Y, et al. : Molecular structure and anti-diabetic activity of a polysaccharide extracted from pumpkin Cucurbita pepo. J.Mol. Struct. 2021; 1239 : 130507. Publisher Full Text Wang S, Lu A, Zhang LU, et al. : Extraction and purification of pumpkin polysaccharides and their hypoglycemic effect. Int. J.Biol. Macromol. 2017; 98 : 182–187. PubMed Abstract | Publisher Full Text World Health Organization: Report of the sixth meeting of the WHO Technical Advisory Group on Diabetes: Virtual Meeting. Geneva: WHO; 2024. Yang Z, Chen S, Sun W, et al. : Study on the mechanisms by which pumpkin polysaccharides regulate abnormal glucose and lipid metabolism in diabetic mice under oxidative stress. Int. J.Biol. Macromol. 2024; 270 : 132249. PubMed Abstract | Publisher Full Text Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 07 Jul 2025 ADD YOUR COMMENT Comment Author details Author details 1 Kampala International University - Western Campus, Bushenyi, Western Region, Uganda 2 Kisii University, Kisii, Kisii County, Kenya 3 Evangel University Akaeze, Okpoto, Ebonyi, Nigeria 4 Southwest University College of Pharmaceutical Sciences, Chongqing, Chongqing, China 5 Jomo Kenyatta University of Agriculture and Technology, Nairobi, Nairobi County, Kenya 6 Federal University of Health Sciences Otukpo, Otukpo, Benue, Nigeria 7 The University of Lahore, Lahore, Punjab, Pakistan 8 Victoria University, Kampala, Central Region, Uganda 9 Usmanu Danfodiyo University, Sokoto, Sokoto, Nigeria 10 Bayero University Faculty of Basic Medical Sciences, Kano, Kano, Nigeria Nancy Bonareri Mitaki Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Software, Writing – Original Draft Preparation Ilemobayo Victor Fasogbon Roles: Conceptualization, Formal Analysis, Methodology, Software, Writing – Original Draft Preparation Augustine Oviosun Roles: Conceptualization, Formal Analysis, Validation, Visualization, Writing – Original Draft Preparation Samuel Mong’are Roles: Data Curation, Investigation, Software, Validation, Visualization Angela Mumbua Musyoka Roles: Conceptualization, Methodology, Resources, Software, Writing – Original Draft Preparation, Writing – Review & Editing Vivian Onyinye Ojiakor Roles: Conceptualization, Formal Analysis, Methodology, Writing – Original Draft Preparation Swase Dominic Terkimbi Roles: Conceptualization, Investigation, Methodology, Validation, Writing – Original Draft Preparation Peter Chinedu Agu Roles: Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation Wusa Makena Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation Robert Siida Roles: Conceptualization, Methodology, Resources, Validation, Writing – Original Draft Preparation Elizabeth Kemunto Mitaki Roles: Data Curation, Investigation, Resources, Software, Validation Ibe Micheal Usman Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Writing – Original Draft Preparation Esther Ugo Alum Roles: Data Curation, Investigation, Software, Visualization, Writing – Original Draft Preparation DANIEL EJIM UTI Roles: Data Curation, Investigation, Resources, Software, Writing – Original Draft Preparation Lucy Aja Roles: Investigation, Resources, Software, Validation, Visualization Sana Noreen Roles: Data Curation, Investigation, Methodology, Software, Validation Tijjani Salihu Shinkafi Roles: Conceptualization, Formal Analysis, Methodology, Software, Supervision, Visualization, Writing – Original Draft Preparation Dayyabu Shehu Roles: Formal Analysis, Investigation, Methodology, Supervision, Validation, Visualization Philippe Mounmbegna Roles: Conceptualization, Methodology, Resources, Software, Supervision, Writing – Original Draft Preparation Patrick Maduabuchi Aja Roles: Conceptualization, Formal Analysis, Methodology, Resources, Supervision, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information The author(s) declared that no grants were involved in supporting this work. Article Versions (1) version 1 Published: 07 Jul 2025, 14:668 https://doi.org/10.12688/f1000research.166533.1 Copyright © 2025 Mitaki NB et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Mitaki NB, Fasogbon IV, Oviosun A et al. Preclinical evidence of the efficacy of cucurbita plants in diabetes management: a systematic review [version 1; peer review: awaiting peer review] . F1000Research 2025, 14 :668 ( https://doi.org/10.12688/f1000research.166533.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: AWAITING PEER REVIEW AWAITING PEER REVIEW ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 07 Jul 2025 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status AWAITING PEER REVIEW Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "Preclinical evidence of the efficacy of cucurbita...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/14-668/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/14-668/v1&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/14-668/v1" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Mitaki NB et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/14-668/v1/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/14-668", templates : { twitter : "Preclinical evidence of the efficacy of cucurbita plants in diabetes.... Mitaki NB et al., published by " + "@F1000Research" + ", https://f1000research.com/articles/14-668/v1" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/166533/183532") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "183532"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "398594": 0, "398595": 0, "398592": 0, "398593": 0, "401582": 0, "401583": 0, "401580": 0, "401581": 0, "401578": 0, "401579": 0, "401576": 0, "401577": 0, "404662": 0, "404663": 0, "404660": 0, "404661": 0, "401584": 0, "401585": 0, "404668": 0, "404669": 0, "404666": 0, "404667": 0, "404664": 0, "404665": 0, "411502": 0, "411503": 0, "411500": 0, "411501": 0, "411499": 0, "408182": 0, "408183": 0, "408180": 0, "411508": 0, "408181": 0, "408178": 0, "411506": 0, "408179": 0, "411507": 0, "411504": 0, "411505": 0, "398590": 0, "398591": 0, "398588": 0, "398589": 0, "398586": 0, "408186": 0, "398587": 0, "408187": 0, "408184": 0, "408185": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "95a7c8e6-4ec5-4d47-a59b-4c98c579d757"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "
[email protected]", infoEmail: "
[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.